RARE
Ultragenyx Pharmaceutical Inc.stockNASDAQ
Market OpenNov 19, 2026 9:54:52 AM EST
17.69USD-0.226%(-0.04)111,777
Pre-marketNov 19, 2026 9:17:30 AM EST
17.70USD-0.169%(-0.03)
RARE Financials
In Q3 FY 2026 (ended ), Ultragenyx Pharmaceutical Inc. (RARE) reported revenue of $173M, net income of −$118M, operating cash flow of −$43M, and assets of $1.19B (filed ).
Loading business breakdowns…